The Air We Breathe May Be Shaping the Future Burden of Blindness

Growing evidence suggests that long-term exposure to air pollution may increase the risk of age-related macular degeneration (AMD), a leading cause of vision loss worldwide. As urban populations continue to grow, researchers are increasingly examining how environmental exposures contribute to eye disease and whether prevention strategies should extend beyond traditional clinical risk factors.

June 9, 2026
Editorial
Researchers are increasingly investigating how long-term exposure to polluted air may contribute to retinal disease and age-related vision loss.

IPM Take

The growing evidence linking air pollution and age-related macular degeneration expands the personalised medicine conversation beyond genetics and clinical risk factors. Environmental exposures may become increasingly important in identifying individuals at elevated risk of vision loss and designing prevention strategies. While causality remains under investigation, the findings reinforce the importance of integrating environmental health considerations into ophthalmology, prevention programmes and population-level eye health planning.

Executive Summary

New research suggests that individuals living in areas with poor air quality may face a higher risk of developing age-related macular degeneration (AMD), one of the leading causes of blindness among older adults. A study published in the British Journal of Ophthalmology found that residents of highly polluted areas were at least 8% more likely to be diagnosed with AMD compared with those living in less polluted environments. Researchers believe chronic exposure to pollutants may contribute to inflammatory processes that damage retinal tissues. Additional evidence from a growing body of literature indicates that both outdoor and indoor air pollution may affect multiple aspects of eye health, including the ocular surface, glaucoma risk, cataract formation and retinal disease. While more research is needed to establish biological mechanisms, the findings highlight air quality as a potentially modifiable risk factor for vision loss

Why it matters

  • Clinicians: Environmental exposure history may become increasingly relevant when assessing AMD risk and advising patients on preventive strategies.
  • Public authorities: Air quality policies may deliver benefits beyond respiratory and cardiovascular health, potentially contributing to reductions in vision-related disease burden.
  • Patients and advocates: Understanding modifiable risk factors such as smoking, cardiovascular health and environmental exposures may help support long-term eye health.
  • Researchers and academia: Further investigation is needed to clarify biological pathways linking pollution exposure with retinal degeneration and visual impairment.

Age-related macular degeneration has long been associated with ageing, genetics and lifestyle factors.

However, a growing body of evidence suggests that the environment in which people live may also play an important role in determining their risk of vision loss.

Recent research published in the British Journal of Ophthalmology found that individuals living in highly polluted areas were more likely to develop age-related macular degeneration (AMD) than those residing in areas with cleaner air. The study reported that residents exposed to poorer air quality faced at least an 8% increased likelihood of receiving an AMD diagnosis.

The findings add to a broader discussion about how environmental factors influence chronic disease and raise important questions for ophthalmology and public health.

A disease of growing importance

AMD affects the macula, the central portion of the retina responsible for detailed vision used for reading, driving and recognising faces.

As damage progresses, patients may experience blurred central vision, distortion of straight lines or the appearance of dark areas within their visual field. In many cases, early disease develops without noticeable symptoms, making routine eye examinations essential for timely detection.

Globally, AMD remains one of the leading causes of irreversible vision loss among older adults and is expected to become increasingly prevalent as populations age.

Why pollution may affect the retina

Although researchers have identified an association between air pollution and AMD, the precise biological mechanisms remain under investigation.

One leading hypothesis involves chronic inflammation.

Air pollutants, including particulate matter (PM2.5 and PM10), nitrogen oxides and ozone, are known to trigger inflammatory responses throughout the body. Inflammation has also been implicated in the development and progression of retinal degeneration.

The retina is particularly vulnerable because of its high metabolic activity and constant exposure to oxidative stress. Long-term environmental insults may contribute to cumulative tissue damage that accelerates disease development.

Experts note that inflammation represents only one possible pathway. Oxidative stress, vascular dysfunction and cellular injury are also being explored as potential mechanisms linking air pollution with retinal disease.

The broader impact of polluted air on eye health

Emerging evidence suggests that AMD may represent only one component of a larger ophthalmic burden associated with poor air quality.

A comprehensive review of air pollution and eye disease found links between environmental pollutants and a range of ocular conditions, including conjunctivitis, dry eye symptoms, glaucoma, cataracts and retinal disease.

The eye is uniquely exposed to the external environment. Unlike many other organs, it is protected primarily by a thin tear film and surface barriers that can be directly affected by airborne particles and chemical pollutants.

Research has demonstrated that exposure to particulate matter, traffic-related pollutants and tobacco smoke can trigger irritation, inflammation and structural changes affecting multiple parts of the eye.

Indoor air pollution may also contribute to risk. Tobacco smoke, poor ventilation, cooking emissions and volatile organic compounds have all been associated with adverse ocular effects in observational studies.

From genetics to environmental risk

AMD is often viewed through the lens of ageing and genetics.

Indeed, genetic factors may account for a substantial proportion of disease susceptibility. However, growing evidence suggests that environmental exposures may help explain why some individuals develop disease while others with similar genetic backgrounds do not.

This shift aligns with broader personalised medicine efforts to understand how genetics, lifestyle, environment and health systems interact to shape individual risk.

While genetic predisposition cannot be modified, environmental and behavioural risk factors may offer opportunities for prevention.

What can patients do today?

Although individuals cannot always control the quality of the air around them, several established strategies remain important for reducing AMD risk.

Avoiding smoking remains one of the most effective preventive measures. Maintaining healthy blood pressure and cholesterol levels, following a balanced diet rich in leafy green vegetables and engaging in regular physical activity can also support retinal health.

Equally important is early detection.

Because AMD often progresses without symptoms in its earliest stages, comprehensive eye examinations remain critical, particularly for older adults and those with known risk factors.

For patients who develop wet AMD, timely diagnosis can significantly improve treatment outcomes and help preserve vision.

Looking ahead

The relationship between environmental exposures and eye disease is likely to attract increasing attention from researchers, policymakers and healthcare systems.

As urbanisation continues worldwide and concerns about air quality grow, understanding the ophthalmic consequences of environmental pollution may become an important component of prevention strategies.

The current evidence does not suggest that air pollution is the sole driver of AMD. Rather, it highlights how environmental factors may interact with genetics, ageing and cardiovascular health to influence disease risk.

For personalised medicine, the message is increasingly clear: protecting vision may require looking beyond the eye itself and considering the broader environments in which people live, work and age.

Source & Evidence